Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06244147 · ClinicalTrials.gov registry record
Long Term Safety and Efficacy of KSM-66 Ashwagandha in Adults
A clinical trial, sponsored by SF Research Institute.
- Completed
- Registry status
- 200
- Enrollment target
NCT06244147: Completed study, sponsored by SF Research Institute.
NCT06244147 is a clinical trial that has completed, run by SF Research Institute. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06244147 has completed, sponsored by SF Research Institute.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
The primary objective is to evaluate the clinical safety of KSM-66 Ashwagandha (Withania Somnifera) on long-term administration over 12 months. The secondary objectives are to evaluate the laboratory safety of KSM-66 Ashwagandha (Withania Somnifera) on long-term administration over 12 months and to evaluate the efficacy of KSM-66 Ashwagandha (Withania Somnifera) on long-term administration over 12 months.
Primary Outcome
Number and proportion of Treatment Emergent Adverse Events (TEAEs) and Treatment Emergent Serious Adverse Event (TESAE) due to KSM-66 Ashwagandha (Withania Somnifera) over 12 months period
Interventions
- DIETARY_SUPPLEMENT KSM-66 Ashwagandha Root Extract
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-02-15 |
| Est. Completion | 2025-10-15 |
What the finished NCT06244147 record still lists
NCT06244147 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which KSM-66 Ashwagandha Root Extract is the first listed.
NCT06244147 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06244147 about?
NCT06244147 is a clinical study titled "Long Term Safety and Efficacy of KSM-66 Ashwagandha in Adults". The primary objective is to evaluate the clinical safety of KSM-66 Ashwagandha (Withania Somnifera) on long-term administration over 12 months. The secondary objectives are to evaluate the laboratory safety of KSM-66 Ashwagandha (Withania Somnifera) on long-term administration over 12 months and to ...
What is the current status of trial NCT06244147?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2024-02-15. Estimated completion is 2025-10-15.
What interventions are being tested in trial NCT06244147?
The interventions under investigation include: KSM-66 Ashwagandha Root Extract (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06244147?
This trial is sponsored by SF Research Institute, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI